Archived record Archived record page of the former CAB Direct database. Not affiliated with its current publisher.
Archive · Plants · Record 20103079746

Commercialization of Mangosteen in the United States

D. Karp's 2010 review traced the long effort to cultivate mangosteen (Garcinia mangostana L.) for the United States market and the regulatory changes that eventually expanded access to fresh fruit. The paper covered small domestic plantings in Hawaii and Puerto Rico, restrictions on fruit that could carry quarantine pests, and the emergence of irradiation-based pathways for mainland marketing.The record captures a transition period in U.S. mangosteen commercialization. By the late 2000s, small domestic harvests and newly permitted imports from Thailand were beginning to move fresh mangosteen beyond the limited markets that had previously characterized its U.S. presence.

What the study did and found

Karp reviewed the history of efforts to cultivate mangosteen in the United States and elsewhere in the Western Hemisphere and to market the fruit in the United States. The paper described mangosteen as native to Indonesia and Malaysia and requiring a fully tropical climate, which prevented commercial cultivation in the contiguous United States.

The review reported that small plantings were established during the 1990s in Hawaii and Puerto Rico, at approximately 30 hectares and 5 hectares respectively. Some of these plantings were beginning to bear fruit by the period covered in the paper. Hawaiian growers chiefly marketed mangosteen to local hotels, restaurants and cruise ships.

Fresh mangosteens could harbor quarantine pests, and APHIS had prohibited imports from the principal producing countries in Southeast Asia and movement from Hawaii to the mainland. Karp reported that a June 2007 final rule permitted fresh Thai mangosteen irradiated at a minimum dose of 400 Gy, while small-scale shipments from Puerto Rico began in August 2007 without an irradiation requirement. In 2008, another final rule permitted Hawaiian mangosteen to reach the mainland after irradiation at a minimum dose of 150 Gy.

Why it is cited

The review is useful because it brings cultivation, plant quarantine and marketing into a single historical account. It shows that U.S. commercialization depended not only on consumer demand but also on where mangosteen could grow and whether fruit could legally move from producing areas to mainland buyers.

The paper also documents a specific regulatory transition. Thailand already led world production, but fresh fruit from the major Southeast Asian producing countries had been excluded because of quarantine concerns. The 2007 import rule therefore created a new commercial route from a major production source rather than relying only on small U.S. tropical plantings.

Karp further noted that imported Thai mangosteen appeared to tolerate the required 400 Gy irradiation dose well. This observation matters to the commercialization narrative because an approved quarantine treatment also had to leave fruit suitable for the market. The paper additionally records growing public awareness associated with purported health benefits of mangosteen products.

Where the evidence stands

The article is a 2010 review of the historical and regulatory situation around U.S. mangosteen commercialization, rather than a current survey of production or trade. Its figures for approximately 30 hectares in Hawaii and 5 hectares in Puerto Rico describe plantings reported for that period. Likewise, the 2007 and 2008 irradiation requirements document the market-access rules discussed by Karp and should not automatically be treated as current regulatory requirements.

The source supports the stated sequence of early mainland shipments from Puerto Rico, irradiated imports from Thailand and later access for Hawaiian fruit. It also supports the distinction between climate limitations and quarantine limitations: mangosteen required fully tropical growing conditions, while fresh-fruit movement was separately constrained by pest concerns. The abstract does not provide detailed shipment volumes, prices, grower returns or consumer-sales data, so those measures should not be inferred from this record.

The topic today

Karp's paper provides a historical baseline for understanding how a specialty tropical fruit can enter a national market. The case links production geography with phytosanitary regulation: domestic cultivation was confined to tropical U.S. areas, while access to larger mainland markets depended on approved pathways for managing quarantine pests.

The review should not be used by itself to describe today's acreage, import volumes or APHIS requirements. Those conditions can change as production expands, pest-risk assessments are revised and trade rules are updated. Its value is in documenting the commercial transition that occurred around 2007–2008.

The broader topic remains relevant to tropical-fruit marketing because regulatory access can shape which producing regions are able to supply consumers. In the mangosteen case, domestic production, imports and phytosanitary treatment were interconnected parts of the market's development rather than separate issues.